Keeren Shah
Financieel Directeur/CFO bij ACTAVIA LIFE SCIENCES, INC.
Vermogen: 118 $ op 31-05-2024
Profiel
Keeren Shah is currently working as a Member at The Chartered Institute of Management Accountants.
Additionally, Ms. Shah holds the position of Chief Financial Officer at OKYO Pharma Ltd., Actavia Life Sciences, Inc., AccuStem Sciences, Inc., and Tiziana Life Sciences Ltd.
In the past, Ms. Shah worked as a Finance Director at Rasna Therapeutics, Inc.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
ACCUSTEM SCIENCES INC
0.00% | 31-12-2023 | 250 ( 0.00% ) | 118 $ | 31-05-2024 |
Actieve functies van Keeren Shah
| Bedrijven | Functie | Begin |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Financieel Directeur/CFO | 31-07-2020 |
| OKYO PHARMA LIMITED | Financieel Directeur/CFO | 01-08-2020 |
| ACCUSTEM SCIENCES, INC. | Financieel Directeur/CFO | 01-08-2021 |
| TIZIANA LIFE SCIENCES LTD | Financieel Directeur/CFO | - |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Eerdere bekende functies van Keeren Shah
| Bedrijven | Functie | Einde |
|---|---|---|
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Health Technology |
| OKYO PHARMA LIMITED | Health Technology |
| TIZIANA LIFE SCIENCES LTD | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
| AccuStem Sciences, Inc. | |
Rasna Therapeutics, Inc. /Old/
Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Distribution Services |
